New collaboration presents big opportunities for UK SMEs |
| Wednesday, 27 January 2010 15:55 |
The recent signing of a co-promotional agreement between myM-link and Medical Device Licensing (a division of UTEK Europe, Ltd.), whereby myM-link will actively promote partnering opportunities from Medical Device Licensing's client companies directly to its member companies, is expected to present large-scale partnering opportunities to smaller companies operating in the UK life sciences market. myM-link is a membership service for private companies in the life sciences market, which gives its members a competitive edge through networking, market intelligence and commercial opportunities. Currently UTEK’s Medical Device Licensing platform offers companies the opportunity to promote their device, diagnostic, delivery and equipment partnering and licensing opportunities on a global scale to the biggest names in the biopharmaceutical, life science and healthcare industries worldwide utilising the service to identify innovative IP and opportunities. This is a specialist market traditionally beyond the reach of smaller life sciences companies in the UK. The agreement between myM-link and UTEK’s Medical Device Licensing group will help to make this market accessible to the smaller UK life sciences companies – a sector that is recognised as playing a vital role in helping drive economic growth and meeting future healthcare needs. Sue Wilde, Manager of myM-link spoke enthusiastically about the arrangement: She continued: "This collaboration comes at a good time for SMEs in the UK, emerging from the recession and looking for new markets. myM-link is continually successful in bringing SMEs together to collaborate on the best use of each other’s technology, products or services for their mutual benefit and advancement, but now they get a chance to show the big boys what they are capable of." "This agreement is definitely a two-way deal;" commented Mark McBride, Managing Director of UTEK Europe, Ltd, "We have recognised myM-link’s integral position as one of the UK’s foremost life sciences membership service and have chosen to partner with them so that global companies utilising our Medical Device Licensing and Pharmalicensing platforms can tap into the type of innovative thinking shown by myM-link’s member companies. We feel there is great potential within the SME community for solutions to be developed addressing issues raised by the partnering and licensing activities of our client companies." Sue Wilde concluded: Private companies in the life sciences market can take advantage of this opportunity by becoming a member of myM-link. |
The Collaborative Healthcare Leadership Programme |
|
20th February 2012 Faced with diminishing resource and budget, Leaders within the NHS are having... |
Pre-clinical Evaluation in Drug Development |
|
7th March 2012 The aim of this unique short course is to provide a detailed insight into the... |
Clinical Evaluation of Medical Technology |
|
13th March 2012 The course is designed to help regulatory professionals understand the fundam... |
Management of Regulatory Affairs & its Contribution to the Medical Technology Lifecycle |
|
12th June 2012 The course is designed to provide students with an understanding of the skill... |